- According to estimates from 13 analysts, 10x Genomics, Inc. stock's average price target has risen from $30.92 to $32.08, with forecasts ranging from $20 to $45 per share
- Based on the Jul. 8 closing price, the updated target implies approximately 14% potential downside
- Consensus rating remains at “Buy” across 16 covering analysts, with 6 Buys, 9 Holds and 1 Sells
Explore more price target data and ratings for 10x Genomics, Inc. on the , and track all previous and future analyst recommendations for 10x Genomics, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.